Prevention of Cardiovascular Diseases with Standard-Dose Quadrivalent Influenza Vaccine in People Aged ≥50 Years in Australia During the 2017 A/H3N2 Epidemic

Prevention of Cardiovascular Diseases with Standard-Dose Quadrivalent Influenza Vaccine in People Aged ≥50 Years in Australia During the 2017 A/H3N2 Epidemic

<b>Background:</b> In Australia, 2017 was a severe A/H3N2 season and, therefore, we estimated the effectiveness of standard-dose quadrivalent influenza vaccine in preventing hospitalization for cardiovascular disease (CVD) among New South Wales (NSW) residents aged ≥50 years. <b>Me...

Full description

Saved in:
Bibliographic Details
Main Authors: Zubair Akhtar, Aye M. Moa, Timothy C. Tan, Ole Fröbert, Robert Menzies, C. Raina MacIntyre
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Series:Vaccines
Subjects:
influenza vaccination
cardiovascular disease (CVD)
hospitalization
vaccine effectiveness
propensity score matching
Online Access:https://www.mdpi.com/2076-393X/13/4/407
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/4/407

Similar Items